生命科学资讯

FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, Truqap

Beam rejigs deal to retain base editing technology amid partner's dissolution

Chutes & Ladders—Bavarian Nordic CEO exits on heels of failed takeover

Servier to widen rare cancer offerings with $2.5B buyout of Day One and glioma drug Ojemda

Senior FDA official refutes uniQure's claims amid controversy over Huntington's gene therapy

Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal

Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug

Tenaya, Alnylam ink research collab to find gene targets for cardio drugs

Pressure builds as back-and-forth between uniQure and FDA intensifies

Alltrna undergoes third layoff round before entering clinic, cutting 35% of jobs

Daiichi Sankyo pens pact with Germany's Gaia to sell digital therapeutic for high cholesterol

VC firm to open 30K-square-foot biotech incubator in Salt Lake City

BCI retinal implant medtech Science closes major $230M series C round

PepGen hit with partial clinical hold, analysts blame 'understaffed FDA'

Guardant hits the road with colon cancer blood test

Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'

Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations

Nvidia dives deeper into medtech, cancer research with Droplet Biosciences

ARPA-H launches $158M effort to aid first-ever lymphatic system medicines

Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option